Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate

Calciphylaxis is a rare, life‐threatening cause of skin necrosis. The condition is primarily reported in patients with end‐stage renal disease, and is associated with significant morbidity and mortality. Treatment has mainly been empirical. We report a case of calciphylaxis in a patient with normal renal function and hypoparathyroidism, who responded to treatment with sodium thiosulfate. To our knowledge, this is the first reported case of the use of sodium thiosulfate to treat calciphylaxis in a patient with normal renal function.

[1]  L. Buescher,et al.  Calciphylaxis responding to sodium thiosulfate therapy. , 2007, Archives of dermatology.

[2]  R. Fennell,et al.  Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[3]  K. Iseki,et al.  Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patient. , 2006, Clinical nephrology.

[4]  M. Meissner,et al.  Sodium Thiosulphate as a Promising Therapeutic Option to Treat Calciphylaxis , 2006, Dermatology.

[5]  B. Bastani,et al.  Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis , 2006, Renal failure.

[6]  D. Serur,et al.  Dialysis Rounds
A Dialysis Case 
Presentation and Discussion
Edited by Roger A. Rodby : Long‐Term Intravenous Sodium Thiosulfate in the Treatment of a Patient with Calciphylaxis , 2005, Seminars in dialysis.

[7]  G. Guerra,et al.  Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Lisa Kolb,et al.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. , 2005, Cardiovascular diabetology.

[9]  D. Spector,et al.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  C. Magro,et al.  Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment , 2002, Seminars in dialysis.